| 英文名称 | 中文名称 | CAS | MF |
|
tributyl(5-hexylthiophen-2-yl)stannane
|
三丁基(5-己基噻吩基)锡
|
388616-37-3
|
C22H42SSn
|
|
3-(4-bromophenyl)-2-[2-(4-fluorophenyl)vinyl]-4(3H)-quinazolinone
|
|
388617-89-8
|
C22H14BrFN2O
|
|
Lacosamide N-Methyl Impurity
|
Lacosamide N-Methyl Impurity
|
388619-64-5
|
C14H20N2O3
|
|
5-Fluoro-6-hydroxy-naphthalene-1-carboxylic acid methyl ester
|
5-氟-6-羟基-萘-1-羧酸甲酯
|
388622-47-7
|
C12H9FO3
|
|
1,6-Naphthalenediol, 5-fluoro-
|
|
388622-50-2
|
C10H7FO2
|
|
7-Dehydrocholesterol-25,26,26,26,27,27,27-d7
|
7-DEHYDROCHOLESTEROL-25,26,26,26,27,27,27-D7
|
388622-58-0
|
C27H44O
|
|
2(1H)-Pyrimidinone,4-methyl-6-(methylamino)-,hydrazone(9CI)
|
2-HYDRAZINYL-N,6-DIMETHYLPYRIMIDIN-4-AMINE
|
388622-91-1
|
C6H11N5
|
|
Cyclopropanecarboxylic acid, 3-(cyanomethyl)-2,2-dimethyl- (9CI)
|
|
388623-23-2
|
C8H11NO2
|
|
2H-1,2,3-Triazole-4,5-dicarboxamide(9CI)
|
|
388623-87-8
|
C4H5N5O2
|
|
1H-1,2,3-Triazole-4-carboxamide,N,1,5-trimethyl-(9CI)
|
|
388623-89-0
|
C6H10N4O
|
|
1H-Pyrazole-4,5-dione, 3-methyl-, 4-(O-ethyloxime) (9CI)
|
|
388624-11-1
|
C6H9N3O2
|
|
TRKA INHIBITOR
|
TRKA INHIBITOR
|
388626-12-8
|
C15H13N3O3S
|
|
3-(2-Pyridin-4-yl-ethyl)-phenylamine
|
3-(2-吡啶-4-基乙基)苯胺
|
388627-91-6
|
C13H14N2
|
|
1,2,4-Oxadiazole-3-carboximidamide,5-ethyl-N-hydroxy-
|
|
388629-93-4
|
C5H8N4O2
|
|
(5-Methyl-1,3,4-thiadiazol-2-yl)methanamine hydrochloride
|
(5-甲基-1,3,4-噻二唑-2-基)甲胺
|
388630-75-9
|
C4H8ClN3S
|
|
2-Pyrrolidinone,1-(2-aminopropyl)-(9CI)
|
|
388630-76-0
|
C7H14N2O
|
|
Cyclopentanecarboxylic acid, 1-amino-3-phenyl- (9CI)
|
|
388631-18-3
|
C12H15NO2
|
|
Cyclopentanemethanol, 1-amino-3-phenyl- (9CI)
|
|
388631-20-7
|
C12H17NO
|
|
Cyclopropanamine, 2-pentyl-, (1R,2R)-rel- (9CI)
|
|
388631-23-0
|
C8H17N
|
|
[(1S,2S)-2-(4-Chlorophenyl)cyclopropyl]methanol
|
[(1S,2S)-2-(4-Chlorophenyl)cyclopropyl]methanol
|
388631-88-7
|
C10H11ClO
|
|
3-(2-Methoxycarbonyl-vinyl)-indole-1-carboxylic acid tert-butyl ester
|
3-(2-甲氧羰基-乙烯基)-吲哚-1-羧酸TERT丁酯
|
388631-93-4
|
C17H19NO4
|
|
4,5-Dihydroxy-2,7-naphthalenedisulfonic acid disodium salt
|
|
388633-48-5
|
C10H6Na2O8S2
|
|
6-Methyl-2-(4-Methylphenyl)-α-oxo-iMidazo[1,2-a]pyridine-3-acetic Acid Ethyl Ester
|
6-Methyl-2-(4-Methylphenyl)-α-oxo-iMidazo[1,2-a]pyridine-3-acetic Acid Ethyl Ester
|
388633-49-6
|
C19H18N2O3
|
|
4-(4-Acetylpiperazin-1-yl)-4-oxobutanoic acid
|
4-(4-乙酰基哌嗪-1-基)-4-氧代丁酸
|
389056-48-8
|
C10H16N2O4
|
|
(1R,2R)-Fmoc-2-aminocyclohexane carboxylic acid
|
FMOC-(1R,2R)-2-氨基环己烷羧酸
|
389057-34-5
|
C22H23NO4
|
|
1,4-dibenzyl-1,4-diazepan-6-ol
|
1,4-dibenzyl-1,4-diazepan-6-ol
|
389062-84-4
|
C19H24N2O
|
|
1H-1,4-Diazepine-2-methanol, hexahydro-
|
|
389062-86-6
|
C6H14N2O
|
|
Proteasome Inhibitor XVI
|
Proteasome Inhibitor XVI
|
389064-25-9
|
C50H88N6O8S
|
|
N-Trityl-1,2-ethanediamine hydrobromide
|
N-三苯甲基乙二胺 氢溴酸盐
|
389064-43-1
|
C21H23BrN2
|
|
Pyridine, 2,3-diethenyl- (9CI)
|
|
389064-82-8
|
C9H9N
|
|
(2-Nitro-phenylamino)-acetic acid methyl ester
|
(2-硝基苯基)甘氨酸甲酯
|
389065-48-9
|
C9H10N2O4
|
|
2-Furancarboxamide,N-(1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-4-
|
|
389066-05-1
|
C11H11N3O4
|
|
389068-22-8
|
389068-22-8
|
389068-22-8
|
C29H37NO
|
|
(2-Benzenesulfonylamino-acetylamino)-acetic acid
|
(2-苯磺酰基氨基乙酰基氨基)-乙酸
|
389070-77-3
|
C10H12N2O5S
|
|
JY-3-094
|
化合物 JY-3-094
|
389076-27-1
|
C13H8N4O5
|
|
2-(2-chlorophenyl)-N-(2-pyridinylmethyl)-4-quinolinecarboxamide
|
|
389081-07-6
|
C22H16ClN3O
|
|
2-(3,4-Dimethoxy-phenyl)-benzooxazol-5-ylamine
|
[2-(3,4-二甲氧苯基)-1,3-苯并恶唑-5-基]胺
|
389081-33-8
|
C15H14N2O3
|
|
2-Pentalenol,octahydro-5,5-dimethyl-,(2-alpha-,3a-bta-,6a-bta-)-(9CI)
|
|
389082-04-6
|
C10H18O
|
|
C30-45 Alkyl dimethicone/polycyclohexene oxide crosspolymer
|
C30-45 烷基聚二甲基硅氧烷/聚环己烯氧化物交联聚合物
|
389082-70-6
|
|
|
Cyclododecane, (1-ethoxyethoxy)-
|
|
389083-83-4
|
C16H32O2
|
|
2-Nitro-1-(2-pyridylthio)-4-(trifluoromethyl)benzene
|
|
389084-12-2
|
C12H7F3N2O2S
|
|
(trans,trans)-4-broMo-4'-ethyl-1,1'-Bicyclohexane
|
反式,反式-4-溴-4'-乙基双环己烷
|
389088-34-0
|
C14H25Br
|
|
1-tert-butylnaphthalen-2-aMine
|
1-(叔丁基)萘-2-胺
|
389104-55-6
|
C14H17N
|
|
9H-Fluoren-2-amine,1-ethyl-(9CI)
|
|
389104-56-7
|
C15H15N
|
|
Carbamic acid, [4-[(4,6-dimethyl-2-pyrimidinyl)thio]phenyl]-, 1,1-dimethylethyl ester (9CI)
|
|
389117-32-2
|
C17H21N3O2S
|
|
Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-methyl- (9CI)
|
|
389117-34-4
|
C12H13N3
|
|
Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-(phenylmethyl)- (9CI)
|
|
389117-35-5
|
C18H17N3
|
|
Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-(2-phenylethyl)- (9CI)
|
|
389117-36-6
|
C19H19N3
|
|
2-Chloro-6-(trifluoromethyl)nicotinonitrile
|
2-氯-6-(三氟甲基)烟腈
|
389117-37-7
|
C15H15N3O3
|
|
Pyrido[2,3-b][1,6]naphthyridine, 7-acetyl-6,7,8,9-tetrahydro- (9CI)
|
|
389117-38-8
|
C13H13N3O
|
|
Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-[3-(trifluoromethyl)benzoyl]- (9CI)
|
|
389117-39-9
|
C19H14F3N3O
|
|
Pyrido[2,3-b][1,6]naphthyridine, 7-[2-(acetyloxy)benzoyl]-6,7,8,9-tetrahydro- (9CI)
|
|
389117-40-2
|
C20H17N3O3
|
|
Pyrido[2,3-b][1,6]naphthyridine, 6,7,8,9-tetrahydro-7-(2-hydroxybenzoyl)- (9CI)
|
|
389117-41-3
|
C18H15N3O2
|
|
Carbamic acid, [(8,9-dihydropyrido[2,3-b][1,6]naphthyridin-7(6H)-yl)thioxomethyl]-, ethyl ester (9CI)
|
|
389117-42-4
|
C15H16N4O2S
|
|
Phenol, 4-chloro-2-(1,8-naphthyridin-2-yl)- (9CI)
|
|
389117-46-8
|
C14H9ClN2O
|
|
Phenol, 3,5-dimethyl-2-(1,8-naphthyridin-2-yl)- (9CI)
|
|
389117-47-9
|
C16H14N2O
|
|
Phenol, 2-(1,8-naphthyridin-2-yl)-, acetate (ester) (9CI)
|
|
389117-48-0
|
C16H12N2O2
|
|
Phenol, 2-(1,8-naphthyridin-2-yl)-, phenylcarbamate (ester) (9CI)
|
|
389117-49-1
|
C21H15N3O2
|
|
1,8-Naphthyridine,2-[2-[(4,6-dimethyl-2-pyrimidinyl)oxy]phenyl]-(9CI)
|
|
389117-50-4
|
C20H16N4O
|
|
Fluocinolone Acetonide Impurity 4
|
氟轻松酮丙酮杂质4
|
389119-98-6
|
C22H28F2O4
|
|
5-[4-(Trifluoromethyl)phenyl]-1,3,4-oxadiazole-2-thiol
|
5-[4-(三氟甲基)苯基]-1,3,4-恶二唑-2-硫醇
|
389120-03-0
|
C9H5F3N2OS
|
|
2,3,8,9,14,15-hexachlorodiquinoxalino[2,3-a:2',3'-c]phenazine
|
2,3,8,9,14,15-六氯二喹喔啉并[2,3-A:2',3'-C]吩嗪
|
389121-44-2
|
C24H6Cl6N6
|
|
3,29-O-dibenzoyloxykarounidiol
|
3,29-二苯甲酰基栝楼仁二醇
|
389122-01-4
|
C44H56O4
|
|
5-Bromo-1H-1,2,4-triazol-3-amine
|
5-溴-1H-1,2,4-3-氨基-1,2,4-三氮唑
|
389122-08-1
|
C2H3BrN4
|
|
1-Benzenesulfonyl-3-ethynyl-1H-indole
|
|
389122-86-5
|
C16H11NO2S
|
|
2-Methyl- (2R)-butanaMide
|
(2R)-2-甲基丁酰胺
|
389122-94-5
|
C5H11NO
|
|
6-oxiran-2-yl-2,3-dihydro-1,4-benzodioxine
|
6-oxiran-2-yl-2,3-dihydro-1,4-benzodioxine
|
389124-25-8
|
C10H10O3
|
|
Halaminol A
|
|
389125-56-8
|
C14H29NO
|
|
Halaminol B
|
|
389125-59-1
|
C12H25NO
|
|
Halaminol C
|
|
389125-68-2
|
C14H29NO
|
|
2-(4-Hydroxyphenyl)-3-methyl-1-[4-[2-(1-piperidinyl)ethoxy]benzyl]-1H-indol-5-ol hydrochloride hydrate
|
2-(4-羟基苯基)-3-甲基-1-[4-[2-(1-哌啶基)乙氧基]苄基]-1H-吲哚-5-醇盐酸盐一水物
|
389125-71-7
|
C29H32N2O3.ClH.H2O
|
|
R-3-iodo-2,2'-bis(MethoxyMethoxy)1,1'-Binaphthalene
|
R-3-IODO-2,2'-BIS(METHOXYMETHOXY)1,1'-BINAPHTHALENE
|
389125-79-5
|
C24H21IO4
|
|
1-Isobenzofurancarboxamide(9CI)
|
|
389126-45-8
|
C9H7NO2
|
|
(R)-2-(2-Propenyl)-2-carboxymethyl-pyrrolidine
|
|
389127-43-9
|
C9H15NO2
|
|
(2R,5S)-5-(3,4-Dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic Acid (1R,2S,5R)-5-Methyl-2-(1-methylethyl)cyclohexyl Ester
|
拉米夫定杂质27
|
389128-28-3
|
C18H26N2O5S
|
|
(S)-(+)-(8,9,10,11,12,13,14,15-Octahydro-3,5-dioxa-4-phospha-cyclohepta[2,1-a:3,4-a']dinaphthalen-4-yl)dimethylamine
|
二-Α-萘二亚胺- 4
|
389130-06-7
|
C22H26NO2P
|
|
4-Pyrimidinecarboxamide, N-ethyl-1,6-dihydro-5-hydroxy-1,2-dimethyl-6-oxo- (9CI)
|
|
389130-73-8
|
C9H13N3O3
|
|
4-Pyrimidinecarboxamide, 1,6-dihydro-5-hydroxy-N,N,1,2-tetramethyl-6-oxo- (9CI)
|
|
389130-74-9
|
C9H13N3O3
|
|
4-Azidobutanol 1-(4-Methylbenzenesulfonate)
|
4-叠氮基丁醇1-(4-甲基苯磺酸盐)
|
389131-94-6
|
C11H15N3O3S
|
|
Omadacycline
|
奥玛环素
|
389139-89-3
|
C29H40N4O7
|
|
NF 449
|
NF449
|
389142-38-5
|
C41H32N6O29S8
|
|
Methyl 2-(5-chloro-2-nitrophenyl)-2-cyanoacetate
|
2-(5-氯-2-硝基苯基)-2-氰基乙酸甲酯
|
389571-34-0
|
C10H7ClN2O4
|
|
Piperlotine A
|
PIPERLOTINE A
|
389572-70-7
|
C14H17NO2
|
|
Pyrrolidine, 1-[[(2R,3S)-3-methyl-2-aziridinyl]carbonyl]-, rel- (9CI)
|
|
389572-78-5
|
C8H14N2O
|
|
2-Aziridinecarboxamide,N,N,3-trimethyl-,(2R,3S)-rel-(9CI)
|
|
389572-79-6
|
C6H12N2O
|
|
2: PN: US20040072744 SEQID: 2 claimed protein
|
389572-87-6
|
389572-87-6
|
C43H67N13O17S
|
|
ent-Paroxol
|
(3R,4S)-4-(4-氟苯基)-3-羟甲基-1-甲基哌啶
|
389573-45-9
|
C13H18FNO
|
|
Prasugrel Hydrochloride
|
普拉格雷盐酸盐
|
389574-19-0
|
C20H20FNO3S.ClH
|
|
Prasugrel (Maleic acid)
|
389574-20-3
|
389574-20-3
|
C24H24FNO7S
|
|
4-chlorobenzoic anhydride:p-chlorobenzoic anhydride
|
|
389577-12-2
|
C14H8Cl2O3
|
|
3(2H)-Benzofuranone, 2-(hydroxymethylene)-
|
|
389579-63-9
|
C9H6O3
|
|
2-[4'-Ethyl(1,1'-biphenyl)-4-yl]-4,6-bis(trichloromethyl)-1,3,5-triazine
|
光固化剂 TAZ-250
|
389579-66-2
|
C19H13Cl6N3
|
|
3-Butynoicacid,2-[[(1,1-dimethylethoxy)carbonyl]amino]-,methylester(9CI)
|
2-[叔丁氧羰基]氨基]-3-丁炔酸甲酯
|
389599-84-2
|
C10H15NO4
|
|
1(3aH)-Pentalenone, 4,5,6,6a-tetrahydro-3,6-dimethyl-, (3aS,6R,6aR)- (9CI)
|
|
389599-94-4
|
C10H14O
|
|
AKOS BAR-2003
|
4'-甲基联苯基-4-甲胺
|
389602-70-4
|
C14H15N
|
|
2-Propyn-1-amine,3-[4-(1-methylethyl)phenyl]-(9CI)
|
|
389602-83-9
|
C12H15N
|
|
4-(1,4-Dioxaspiro[4,5]dec-8-yl) benzenamine
|
4-(1,4-二氧杂螺[4.5]癸烷-8-基)苯胺
|
389602-90-8
|
C14H19NO2
|
|
4-Amino-N-(tetrahydro-2-furanylmethyl)-benzenesulfonamide
|
4-氨基-N-(四氢呋喃甲基)苯磺酰胺
|
389605-69-0
|
C11H16N2O3S
|
|
4-Amino-N-(2,2,2-trifluoroethyl)benzenesulfonamide
|
4-氨基-N-(2,2,2-三氟乙基)苯-1-磺酰胺
|
389605-71-4
|
C8H9F3N2O2S
|
|
2,4-Dichloro-pyrimidine-5-carboxylic acid-tert-butylamide
|
2,4-DICHLORO-PYRIMIDINE-5-CARBOXYLIC ACID-TERT-BUTYLAMIDE
|
389606-35-3
|
C9H11Cl2N3O
|